Latest Advances

  • Condition: COVID-19
  • Journal: Indian journal of pharmacology
  • Treatment Used: Steroid Therapy
  • Number of Patients: NULL
  • Published —
In this study, researchers evaluated the safety and effectiveness of steroid therapy for the treatment of COVID-19.
  • Condition: Coronavirus Infection
  • Journal: Kardiologiia
  • Treatment Used: Bromhexine and Spironolactone
  • Number of Patients: 103
  • Published —
This study evaluated the effectiveness and safety of bromhexine (medication that is used to treat chest congestion and cough) and spironalactone (used to treat high blood pressure and heart failure) in patients with coronavirus (a pandemic infection caused by a coronavirus) infection requiring hospitalization.
  • Condition: Patients with Diabetes Amidst the Covid-19 Pandemic
  • Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • Treatment Used: Probiotics
  • Number of Patients: 0
  • Published —
This review of the literature examined data concerning gut microbiota influences on COVID-19 in patients with diabetes.
  • Condition: Viral Respiratory Infections
  • Journal: BMJ open
  • Treatment Used: Non-Steroidal Anti-Inflammatory Drugs
  • Number of Patients: NULL
  • Published —
The study researched the use of non-steroidal anti-inflammatory drugs in patients with viral respiratory infections.
  • Condition: COVID-19
  • Journal: International immunopharmacology
  • Treatment Used: Convalescent Plasma (CP)
  • Number of Patients: 0
  • Published —
This review of the literature evaluated the use of convalescent plasma (CP) in the treatment of patients with COVID-19.
  • Condition: Rheumatologic Disorders During COVID-19 Pandemic
  • Journal: Reumatismo
  • Treatment Used: Biological Therapy
  • Number of Patients: 1
  • Published —
This case report describes a 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, disease-modifying anti-rheumatic Drugs (DMARDs), and biologic agents diagnosed with COVID-19 treated with supportive care, lopinavir/ritonavir 400/100 mg twice daily, oseltamivir (75 mg) twice daily, hydroxychloroquine (400 mg), decreased methotrexate, and continued azathioprine and adalimumab.
  • Condition: COVID-19
  • Journal: The American journal of Chinese medicine
  • Treatment Used: Glycyrrhizin
  • Number of Patients: NULL
  • Published —
In this study, researchers evaluated the outcomes of using glycyrrhizin for the treatment of COVID-19.
  • Condition: Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome
  • Journal: Critical care (London, England)
  • Treatment Used: Corticosteroid Therapy
  • Number of Patients: 382
  • Published —
This study compared the risk of death between patients with COVID-19-related-acute respiratory distress syndrome treated with corticosteroid treatment and those without.
  • Condition: QT Interval in Patients With COVID-19
  • Journal: Kardiologiia
  • Treatment Used: Azithromycin and Hydroxychloroquine
  • Number of Patients: 0
  • Published —
This article discusses the potential risks involving the QT interval related to the drug treatment of COVID-19 with azithromycin and hydroxychloroquine.
  • Condition: COVID-19
  • Journal: Scientific reports
  • Treatment Used: Tocilizumab
  • Number of Patients: 274
  • Published —
This study assessed the use of tocilizumab in COVID-19 patients with cytokine storm and determined the effect on mortality.
  • Condition: Hospitalized Frail Elderly COVID-19 Patients
  • Journal: Nutrients
  • Treatment Used: Vitamin D Supplementation
  • Number of Patients: 77
  • Published —
This study determined whether bolus vitamin D supplementation before or after COVID-19 infection was effective in improving survival among hospitalized frail elderly patients.
  • Condition: COVID-19
  • Journal: International journal of clinical pharmacology and therapeutics
  • Treatment Used: Oral Polyvalent Immunoglobulins
  • Number of Patients: NULL
  • Published —
The study researched the outcomes of using oral polyvalent immunoglobulins for COVID-19.
Showing 1-12 of 966